Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Post by weetonyon Jul 01, 2012 8:53pm

814 Views

Post# 20073890

started 2009 and kicked face ereryday???

Date	Insider:	Shares	Transaction	Value

03/29/12	Embro-Pantalony, Vaughn, Director of Issuer	185,185	Acquisition or disposition carried out privately at .27 - .27 per share.	$50,000
03/01/10	Embro-Pantalony, Vaughn, Director of Issuer	5,000	Acquisition or disposition in the public market at .43 - .43 per share.	$2,125
03/01/10	Embro-Pantalony, Vaughn, Director of Issuer	35,000	Acquisition or disposition in the public market at .42 - .42 per share.	$14,700
03/01/10	Embro-Pantalony, Vaughn, Director of Issuer	24,000	Acquisition or disposition in the public market at .43 - .43 per share.	$10,320
02/26/10	Embro-Pantalony, Vaughn, Director of Issuer	5,500	Acquisition or disposition in the public market at .40 - .40 per share.	$2,200
02/26/10	Embro-Pantalony, Vaughn, Director of Issuer	500	Acquisition or disposition in the public market at .41 - .41 per share.	$205
02/26/10	Embro-Pantalony, Vaughn, Director of Issuer	48,500	Acquisition or disposition in the public market at .43 - .43 per share.	$20,613
02/26/10	Embro-Pantalony, Vaughn, Director of Issuer	44,500	Acquisition or disposition in the public market at .39 - .39 per share.	$17,355
12/01/09	Embro-Pantalony, Vaughn, Director of Issuer	50,000	Exercise of options at .35 - .35 per share.	$17,500

Date	Insider:	Shares	Transaction	Value

06/28/12	Renner, Joseph David, Director of Issuer	500,000	Acquisition or disposition carried out privately at .30 - .30 per share.	$150,000
03/29/12	Renner, Joseph David, Director of Issuer	185,185	Acquisition or disposition carried out privately at .27 - .27 per share.	$50,000
02/08/12	Renner, Joseph David, Director of Issuer	169,500	Acquisition or disposition in the public market at .20 - .20 per share.	$33,731
02/08/12	Renner, Joseph David, Director of Issuer	25,000	Acquisition or disposition in the public market at .19 - .19 per share.	$4,850
02/08/12	Renner, Joseph David, Director of Issuer	128,500	Acquisition or disposition in the public market at .19 - .19 per share.	$24,286
02/08/12	Renner, Joseph David, Director of Issuer	15,000	Acquisition or disposition in the public market at .18 - .18 per share.	$2,760
04/19/11	Renner, Joseph David, Director of Issuer	650,000	Acquisition or disposition under a prospectus exemption at .35 - .35 per share.	$227,500
04/19/11	Renner, Joseph David, Director of Issuer	650,000	Acquisition or disposition under a prospectus exemption at .35 - .35 per share.	$227,500
02/12/10	Renner, Joseph David, Director of Issuer	890,000	Acquisition or disposition under a prospectus exemption at .35 - .35 per share.	$311,500